Skip to main content
Michael Haggenmueller

Dr. Yuval Rinkevich

Director, IRBM
+49 89 3187 4685Email meBuilding/Room: Großhadern/ 2nd floor/C3.11

“Regenerative medicine encompasses our scientific desire to understand and capitalize on nature’s tools for healing. Our goal is to uncover novel tissue repair mechanisms that can be exploited to restore diseased and injured tissues..”

“Regenerative medicine encompasses our scientific desire to understand and capitalize on nature’s tools for healing. Our goal is to uncover novel tissue repair mechanisms that can be exploited to restore diseased and injured tissues.”

Academic Pathway & Research Area

Dr. Rinkevich has been working at the cutting edge of our understanding of tissue/organ repair and regeneration for over 20 years. His passion and commitment to understanding healing responses and tissue rejuvenation has led his career track from the point of obtaining his PhD degree from the Technion-Israel Institute of Technology, where he studied whole body regeneration from single blood vessels in Protochordates.  Dr Rinkevich moved to Stanford University in the US where he investigated pivotal cellular lineages and stem cells in coordinating mammalian tissue repair and regeneration. His work at Stanford projected Dr Rinkevich into the forefront of the tissue repair field, uncovering the role of Engrailed-1 positive cells in the transition from scarless to scar forming tissue responses.

Today Dr Rinkevich is the Director of the Helmholtz Institute of Regenerative Biology and Medicine at the Helmholtz Center, Munich, Germany. His lab fuses a focus on basic biology, continuing to push forward our understanding of tissue/organ repair and regeneration, with a vision to applying these findings to drug development strategies and translation to the clinic. Publication in high impact journals including Nature and Science, numerous patents and supported by prestigious awards such as the ERC Consolidator Grant, highlight the quality of his team’s work. Dr Rinkevich’s latest work describing the role of fascia and transfer of extracellular matrix in tissue scarring and fibrosis in multiple organ systems is reinventing the way we look at tissue repair and regeneration. These findings provide a new perspective on the potential for clinical intervention, opening our minds to a revolution in antifibrotic therapy, a clinical area impacting fields of medicine from oncology to hepatology and pulmonology, and the potential to prevent and potentially resolve fibrotic disease.

Fields of Work and Expertise

Developmental Biology Stem Cell BiologyPathologyTissue Repair and Regeneration Fibrosis ScarringHealing Extra-cellular Matrix 

Professional Background

since 2021

Director, Institute of Regenerative Biology and Medicine

2019-2021

Tenured Principal Investigator / Helmholtz Zentrum München

2015-2019

PI, Helmholtz Center Munich

2014-2015

Basic Life Science Research Associate, Stanford University

2008-2014

Post doctorate, Stanford University

2003-2008

Doctorate in Biology (PhD), Israel Institute of Technology

2001-2003

Master of Science (MSc), Israel Institute of Technology

1997-2000

Bachelor of Science (BSc), Faculty of Life Sciences, Tel-Aviv University

Honors and Awards

2016
HFSP Career Development Award

Honors and Awards

2021
Employee of the Year Award
2020
The Innovative Research Award
2020
The Research Excellence Award

Publications

Read more